Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
10.43
-0.07 (-0.67%)
Jan 16, 2026, 1:00 PM EST - Market open
DAWN Market Cap
DAWN has a market cap or net worth of $1.07 billion as of January 16, 2026. Its market cap has decreased by -15.59% in one year.
Market Cap
1.07B
Enterprise Value
629.41M
1-Year Change
-15.59%
Ranking
Category
Stock Price
$10.43
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has increased from $965.40M to $1.07B, an increase of 10.93%. That is a compound annual growth rate of 2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 1.08B | 12.66% |
| Dec 31, 2025 | 956.94M | -25.11% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
| May 27, 2021 | 965.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |